Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    eLife · 2025
    MDMarilena D'AurelioQCQiuying Chen
    PMID: 40100251PMCID: PMC11919253DOISenior author
  2. 2
    The Journal of investigative dermatology · 2021
    QCQiuying ChenJZJonathan Zippin
    PMID: 33549605PMCID: PMC8830938DOIFirst author19 citations
  3. 3
    Neurobiology of disease · 2020
    QCQiuying ChenHKHibiki Kawamata FujitaGMGiovanni Manfredi
    PMID: 32745521PMCID: PMC7491150DOIFirst author12 citations

Publications

83 publications

Funding

24 grantsView NIH portfolio on RePORTER ↗

Active

11 grants
  • Co-I
    Mechanisms of cAMP-dependent regulation of melanosome pH
    National Inst of Arthritis & Musculoskeletal & Skin Diseases · 2021–2031· 2 renewals
    R01AR077664-06
  • Co-I
    Tri-I Training Program in Metabolomics
    National Institute of Allergy and Infectious Diseases · 2025–2030Training
    R25AI140472-06A1
  • Co-I
    The Role of NAD+ Metabolism in Obesity-Induced Pancreatic Beta-Cell Dysfunction
    National Institute of Diabetes and Digestive and Kidney Diseases · 2025–2030
    R01DK143009-01
  • Co-I
    Modulating ER stress-induced lipotoxicity to ameliorate mitochondrial myopathy
    Muscular Dystrophy Associations of America, Inc. · 2026–2029
    MDAAA 1454620
  • Co-I
    Metabolic landscape and mitochondrial ROS balance in brain ischemia/reperfusion
    National Institute of Neurological Disorders and Stroke · 2024–2028
    R01NS131322-01A1
  • Co-I
    Mechanisms of Obesity-induced Atrial Fibrillation
    National Heart, Lung, and Blood Institute · 2025–2028
    R01HL177651-01
  • Co-I
    Modulating ER stress-induced lipotoxicity to ameliorate mitochondrial myopathy
    National Inst of Arthritis & Musculoskeletal & Skin Diseases · 2026–2028
    R21AR087068-01
  • Co-I
    Targeting GDF15-GFRAL signaling in mitochondrial myopathies
    National Inst of Arthritis & Musculoskeletal & Skin Diseases · 2025–2027
    R21AR085715-01
  • Co-I
    Pre-malignant mutation landscape and risk factors for progression to hematologic cancers
    National Cancer Institute · 2021–2027
    R01CA248747-04
  • KP
    "Intervention Strategies for Non-Folate Responsive Neural Tube Defects"
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2021–2026 · via Baylor College of Medicine
    R01HD083809-07A1
  • MPI
    Metabolic remodeling of skeletal muscle in mitochondrial myopathies
    National Inst of Arthritis & Musculoskeletal & Skin Diseases · 2020–2026
    R01AR076029-05
Completed grants (13)
  • Co-I
    Dissecting the Cellular and Molecular Links Between Atrial Fibrillation and Obesity
    American Heart Association · 2022–2025
    AHA 970240-01
  • Co-I
    Metabolic origin of oxidative stress injury in brain ischemia/reperfusion
    National Institute of Neurological Disorders and Stroke · 2022–2025
    R21NS125466-02
  • MPI
    Pho-m6A assay: A phosphoselective method to quantify dynamics of m6A in mRNA
    National Institute of Environmental Health Sciences · 2020–2024
    R21ES032347-02
  • MPI
    Modulation Of Intermediate Metabolism, A New Therapeutic Approach For Mitochondrial Encephalomyopathies
    National Institute of Neurological Disorders and Stroke · 2021–2023
    R21NS118233-01A1
  • Co-I
    Risk Genes and Environment Interactions in NTDs
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2016–2022
    P01HD067244-10
  • KP
    Cell Cycle Reprogramming for Therapeutic Targeting of BTK in Lymphoma
    National Cancer Institute · 2014–2021
    R01CA188794-05
  • Co-I
    Metabolic Profiling of sALS: From Fibroblasts to Motor Neurons
    National Institute of Neurological Disorders and Stroke · 2015–2020
    R01NS093872-01
  • KP
    HIV+ Alveolar Macrophage Oxidant-Mediated Apoptosis of Pulmonary Endothelium
    National Heart, Lung, and Blood Institute · 2013–2019
    U01HL121828-03
  • KP
    Urine Metabolomics for the Noninvasive Diagnosis of Antibody Mediated Rejection in Kidney Allografts
    National Institute of Allergy and Infectious Diseases · 2016–2018
    R37AI051652-13
  • KP
    Diabetic Vasculopathy and Mitochondrial eNOS
    National Heart, Lung, and Blood Institute · 2012–2018
    R37HL087062-09
  • KP
    mRNA Methylation: A Novel Mechanism That Blocks Signaling by Drugs of Abuse
    National Institute on Drug Abuse · 2016–2017
    R01DA037150-04S1
  • KP
    Novel Biomarkers for Diabetic Heart Disease
    National Heart, Lung, and Blood Institute · 2013–2014 · via Washington University, The
    P20HL113444-02
  • KP
    Endothelial Dysfunction, Nitric Oxide and Renal Failure
    National Institute of Diabetes and Digestive and Kidney Diseases · 2011–2013 · via New York Medical College
    R01DK045462-15